© Reuters
CAR
+2.77%
Add to/Remove from Watchlist
Add to Watchlist
Add Position
Position added successfully to:
Please name your holdings portfolio
Type:
BUY
SELL
Date:
Amount:
Price
Point Value:
Leverage:
1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000
Commission:
Create New Watchlist
Create
Create a new holdings portfolio
Add
Create
+ Add another position
Close
BLUE
+1.21%
Add to/Remove from Watchlist
Add to Watchlist
Add Position
Position added successfully to:
Please name your holdings portfolio
Type:
BUY
SELL
Date:
Amount:
Price
Point Value:
Leverage:
1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000
Commission:
Create New Watchlist
Create
Create a new holdings portfolio
Add
Create
+ Add another position
Close
QTWO
+5.32%
Add to/Remove from Watchlist
Add to Watchlist
Add Position
Position added successfully to:
Please name your holdings portfolio
Type:
BUY
SELL
Date:
Amount:
Price
Point Value:
Leverage:
1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000
Commission:
Create New Watchlist
Create
Create a new holdings portfolio
Add
Create
+ Add another position
Close
IFS
+0.28%
Add to/Remove from Watchlist
Add to Watchlist
Add Position
Position added successfully to:
Please name your holdings portfolio
Type:
BUY
SELL
Date:
Amount:
Price
Point Value:
Leverage:
1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000
Commission:
Create New Watchlist
Create
Create a new holdings portfolio
Add
Create
+ Add another position
Close
By Davit Kirakosyan
Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: upgrades at Avis Budget, Q2, bluebird bio, Equitrans Midstream, and Financial Services.
InvestingPro subscribers got this news first. Never miss another market-moving headline.
Avis stock gains on Deutsche Bank’s upgrade
Avis Budget Group (NASDAQ:CAR) shares gained more than 2% yesterday after Deutsche Bank upgraded the company to Buy from Hold and raised its price target to $263.00 from $239.00, as InvestingPro reported in real time.
The firm mentioned that the stock has been “left behind without cause,” and emphasized the upgrade’s main focus on the company’s valuation.
Furthermore, the bank highlighted a potential catalyst in the form of expected share repurchases in the latter half of the year. Shares have significantly underperformed comparable travel and leisure sub-sectors year-to-date, lagging behind by an average of 2,400 basis points. The firm believes that the stock could attract investors looking to buy reasonably priced laggards as the S&P 500 sits near a 9-month high.
Q2 upgraded to Buy, shares surge 5%
Q2 (NYSE:QTWO) shares rose more than 5% yesterday after BTIG upgraded the company to Buy from Neutral with a price target of $36.00, highlighting its increasingly constructive view of the long-term outlook for the company.
The firm believes Q2’s guidance is now conservative and much of the potential downside has been stripped out, while growth upside is more tangible than in recent years.
2 more upgrades
Bluebird bio (NASDAQ:BLUE) shares jumped more than 6% premarket today after Barclays upgraded the company to Overweight from Equalweight and raised its price target to $8.00 from $7.00.
JPMorgan upgraded Intercorp Financial Services (NYSE:IFS) to Overweight from Neutral with a price target of $27.00.
Amid an endless firehose of market headlines, jump on the most important ones to fatten your profits: Always be the first to know with InvestingPro.
Start your free 7-day trial now.
Source: Investing.com
